Evolent Health Inc [NYSE: EVH] gained 1.91% or 0.19 points to close at $10.16 with a heavy trading volume of 3993527 shares.
The daily chart for EVH points out that the company has recorded -51.27% loss over the past six months.
If we look at the average trading volume of 2.71M shares, EVH reached to a volume of 3993527 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Evolent Health Inc [EVH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EVH shares is $20.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EVH stock is a recommendation set at 1.13. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Evolent Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 10, 2025. While these analysts kept the previous recommendation, BTIG Research dropped their target price from $36 to $29. The new note on the price target was released on December 03, 2024, representing the official price target for Evolent Health Inc stock. Previously, the target price had yet another drop from $38 to $16, while Stephens kept a Equal-Weight rating on EVH stock.
The Average True Range (ATR) for Evolent Health Inc is set at 0.78, with the Price to Sales ratio for EVH stock in the period of the last 12 months amounting to 0.48. The Price to Book ratio for the last quarter was 1.13, with the Price to Cash per share for the same quarter was set at 0.97. Price to Free Cash Flow for EVH in the course of the last twelve months was 10.81 with Quick ratio for the last quarter at 1.04.
Trading performance analysis for EVH stock
Evolent Health Inc [EVH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -19.37. With this latest performance, EVH shares dropped by -10.72% in over the last four-week period, additionally sinking by -51.27% over the last 6 months – not to mention a drop of -67.26% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EVH stock in for the last two-week period is set at 33.51, with the RSI for the last a single of trading hit 30.64, and the three-weeks RSI is set at 34.00 for Evolent Health Inc [EVH]. The present Moving Average for the last 50 days of trading for this stock 12.82, while it was recorded at 11.25 for the last single week of trading, and 22.34 for the last 200 days.
Evolent Health Inc [EVH]: A deeper dive into fundamental analysis
Evolent Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.04 and a Current Ratio set at 1.04.
An analysis of Institutional ownership at Evolent Health Inc [EVH]
There are presently around $114.49%, or 116.91%% of EVH stock, in the hands of institutional investors. The top three institutional holders of EVH stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 11.17 million shares, which is approximately 9.785%. VANGUARD GROUP INC, holding 11.06 million shares of the stock with an approximate value of $$211.39 million in EVH stocks shares; and VANGUARD GROUP INC, currently with $$166.1 million in EVH stock with ownership which is approximately 7.6108%.
